1）Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-23.4）Feike Y, Zhijie L, Wei C. Advances in research on pharmacotherapy of sarcopenia. Aging Med（Milton) 2021; 4: 221-33.6）Kaasik P, Umnova M, Pehme A, Alev K, Aru M, Selart A, et al. Ageing and dexamethasone associated sarcopenia: Peculiarities of regeneration. J Steroid Biochem Mol Biol 2007; 105: 85-90.2）Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16-31.3）Mayhew AJ, Amog K, Phillips S, Parise G, McNicholas PD, de Souza RJ, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing 2019; 48: 48-56.5）Lindquist M. VigiBase, the WHO Global ICSR Database System: Basic Facts. Drug Information Journal 2008; 42: 409-19.7）Krämer A, Green J, Pollard J, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 2014; 30: 523-30.医療ビッグデータを用いたサルコペニア治療薬の開発文 献 8）Eisenstadt WS. A clinical evaluation of chlor-trimeton. J Lancet 1950; 70: 26. 9）Larsson L, Degens H, Li M, Salviati L, Lee Yi, Thompson W, et al. Sarcopenia: Aging-related loss of muscle mass and function. Physiol Rev 2019; 99: 427-511.10）Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: Molecular mechanisms and promising therapies. Nat Rev Drug Discov 2014; 14: 58-74.11）Lach-Trifilieff E, Minetti GC, Sheppard K, Ibebunjo C, Feige JN, Hartmann S, et al. An antibody blocking activin type Ⅱ receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol Cell Biol 2014; 34: 606-18.12）Latres E, Pangilinan J, Miloscio L, Bauerlein R, Na E, Potocky TB, et al. Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skelet Muscle 2015; 5: 34.13）Camporez JPG, Petersen MC, Abudukadier A, Moreira GV, Jurczak MJ, Friedman G, et al. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice. Proc Natl Acad Sci U S A 2016; 113: 2212-7.45
元のページ ../index.html#59